Small Cell Lung Cancer Patients Can Benefit from Immunotherapy episode artwork

EPISODE · Jun 30, 2015 · 4 MIN

Small Cell Lung Cancer Patients Can Benefit from Immunotherapy

from GRACEcast · host cancerGRACE Meetings

The current standard of care for SCLC shows limited results with high toxicities. Drs. Soria, Gandhi, and West discuss new ASCO 2015 data that show promise for a subset of patients with PD-L1 expression on Keytruda (pembrolizumab) or Opdivo (nivolumab).

Episode metadata supplied by the publisher feed · Published Jun 30, 2015

Embed this episode

NOW PLAYING

Small Cell Lung Cancer Patients Can Benefit from Immunotherapy

0:00 4:46

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of GRACEcast?

This episode is 4 minutes long.

When was this GRACEcast episode published?

This episode was published on June 30, 2015.

Can I download this GRACEcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!